Pfizer
27,80 $Variación respecto al cierre anterior: −1,14 %Variación absoluta: −0,32 $
En resumen
- Crecimiento de los ingresos
- −1,65 %
- 2025 frente a 2024
- Crecimiento del beneficio neto
- −3,24 %
- 2025 frente a 2024
- Margen neto
- 12,4 %
- 2024: 12,6 %
Datos financieros
Importes en millones de USD; valores por acción en USD; acciones en millones.
| Partida | T2 2026 | T1 2026 | T4 2025 | T3 2025 | T1 2025 | T4 2024 | T3 2024 | T2 2024 | T1 2024 | T4 2023 | T3 2023 | T2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Flujo de caja operativo | 835 | 2.615 | 5.348 | 4.603 | 2.335 | 6.721 | 6.714 | -1.781 | 1.090 | 5.240 | 3.456 | -1.208 |
| Amortizaciones | 1.611 | 1.610 | 1.660 | 1.658 | 1.614 | 1.788 | 1.747 | 1.727 | 1.732 | 1.666 | 1.555 | 1.568 |
| Inversiones de capital (capex) | -533 | -436 | -845 | -602 | -564 | -917 | -651 | -637 | -704 | -1.044 | -810 | -914 |
| Flujo de caja de inversión | 2.106 | 785 | -6.146 | -2.430 | 3.274 | -1.623 | -2.057 | 4.600 | 1.732 | -10.996 | 888 | -25.485 |
| Flujo de caja de financiación | -3.663 | -2.856 | 596 | -2.477 | -5.227 | -5.114 | -4.636 | -2.459 | -4.931 | 5.442 | -3.779 | 27.174 |
| Dividendos pagados | -2.451 | -2.445 | -2.445 | -2.444 | -2.437 | -2.380 | -2.380 | -2.380 | -2.372 | -2.315 | -2.314 | -2.315 |
| Emisión de deuda | — | — | 5.991 | 0,0 | — | 732 | 2.161 | 4.570 | 1.444 | 7.672 | -22,0 | 30.630 |
| Amortización de deuda | -1.186 | -127 | -2.906 | 6,0 | -2.434 | -3.452 | -4.411 | -4.586 | -3.617 | 103 | -1.406 | -1.000 |
| Efecto del tipo de cambio | -4,0 | 19,0 | 5,0 | 2,0 | -7,0 | -29,0 | 9,0 | -18,0 | -28,0 | -1,0 | -32,0 | -5,0 |
| Variación neta de efectivo | -726 | 563 | -197 | -300 | 374 | -45,0 | 29,0 | 343 | -2.137 | -315 | 535 | 475 |
| Flujo de caja libre | 302 | 2.179 | 4.503 | 4.001 | 1.771 | 5.804 | 6.063 | -2.418 | 386 | 4.196 | 2.646 | -2.122 |
| Flujo de caja libre apalancado | 2.849 | 418 | 7.060 | 1.706 | 1.472 | 7.435 | 3.352 | 1.817 | -801 | 11.171 | -4.512 | 1.896 |